Important Information

This website is managed by Ultima Markets’ international entities, and it’s important to emphasise that they are not subject to regulation by the FCA in the UK. Therefore, you must understand that you will not have the FCA’s protection when investing through this website – for example:

  • You will not be guaranteed Negative Balance Protection
  • You will not be protected by FCA’s leverage restrictions
  • You will not have the right to settle disputes via the Financial Ombudsman Service (FOS)
  • You will not be protected by Financial Services Compensation Scheme (FSCS)
  • Any monies deposited will not be afforded the protection required under the FCA Client Assets Sourcebook. The level of protection for your funds will be determined by the regulations of the relevant local regulator.

Note: Ultima Markets is currently developing a dedicated website for UK clients and expects to onboard UK clients under FCA regulations in 2026.

If you would like to proceed and visit this website, you acknowledge and confirm the following:

  • 1.The website is owned by Ultima Markets’ international entities and not by Ultima Markets UK Ltd, which is regulated by the FCA.
  • 2.Ultima Markets Limited, or any of the Ultima Markets international entities, are neither based in the UK nor licensed by the FCA.
  • 3.You are accessing the website at your own initiative and have not been solicited by Ultima Markets Limited in any way.
  • 4.Investing through this website does not grant you the protections provided by the FCA.
  • 5.Should you choose to invest through this website or with any of the international Ultima Markets entities, you will be subject to the rules and regulations of the relevant international regulatory authorities, not the FCA.

Ultima Markets wants to make it clear that we are duly licensed and authorised to offer the services and financial derivative products listed on our website. Individuals accessing this website and registering a trading account do so entirely of their own volition and without prior solicitation.

By confirming your decision to proceed with entering the website, you hereby affirm that this decision was solely initiated by you, and no solicitation has been made by any Ultima Markets entity.

I confirm my intention to proceed and enter this website

Moderna Stock Jumps Over Astounding Profits 

um editor

UM Editor

February 23, 2024 at 11:17 am

Shares of Moderna (MRNA.US) experienced a significant increase on Thursday as it reported a surprising profit and surpassed Wall Street’s quarterly forecasts. The Covid vaccine producer announced earnings of $0.55 per share on $2.8 billion in revenue for the fourth quarter, shattering FactSet analysts’ predictions of a $0.99 per share loss on $2.5 billion in sales. 

According to Chief Financial Officer Jamey Mock, this unexpected earnings result is partially due to a $600 million deferral in revenue. In a promising turn of events, Moderna continues to deliver on its pledge to trim its expenses. The expense for goods sold over the past year was noted to be $4.7 billion, undercutting the estimated figure of $5 billion. Nonetheless, the firm’s sales during the fourth quarter underwent a 45% reduction on a year-on-year basis, a dip largely attributed to the decreased sales of the company’s Covid-19 vaccine, as stated in Moderna’s press release. Correspondingly, the earnings also faced an 85% downfall. 

For the entire 2023, Moderna disclosed revenues of $6.8 billion, which is a 64% decrease when compared with the previous year, and a per-share loss of $12.33, a stark contrast to the $20.12 earnings per share registered in 2022. 

Moderna is currently seeking new opportunities by focusing on its mRNA technology for developing other pharmaceuticals, which include a respiratory syncytial virus (RSV) vaccine that is ready to challenge vaccines from two leading competitors — Pfizer (PFE.US) and GSK (GSK.US). 

Moderna stock jumped 13.5% to 99.44, following earnings releases. As for prospects, Moderna reaffirmed its forecast of $4 billion in sales for 2024, accompanied by research and development costs amounting to $4.5 billion. 

(Moderna Stock Performance One-year Chart) 

Disclaimer  

Comments, news, research, analysis, price, and all information contained in the article only serve as general information for readers and do not suggest any advice. Ultima Markets has taken reasonable measures to provide up-to-date information, but cannot guarantee accuracy, and may modify without notice. Ultima Markets will not be responsible for any loss incurred due to the application of the information provided. 

Why Trade Metals & Commodities with Ultima Markets?

Ultima Markets provides the foremost competitive cost and exchange environment for prevalent commodities worldwide.

Start Trading

  • Monitoring the market on the go

  • Markets are susceptible to changes in supply and demand

  • Attractive to investors only interested in price speculation

  • Deep and diverse liquidity with no hidden fees

  • No dealing desk and no requotes

  • Fast execution via Equinix NY4 server

Market

Platform

Account

Resources

About

FOLLOW US

App Store Google Play
FSC icon

Ultima Markets is a member of The Financial Commission, an international independent body responsible for resolving disputes in the Forex and CFD markets.

WTW icon

All clients of Ultima Markets are protected under insurance coverage provided by Willis Towers Watson (WTW), a global insurance brokerage established in 1828, with claims eligibility up to US$1,000,000 per account.  

united icon

Ultima Markets is the first CFD broker to be part of United Nations Global Compact.

FOLLOW US

TRADE WITH US

App Store Google Play

RISK DISCLOSURE

Risk Warning:
Trading leveraged financial products, including Contracts for Difference (CFDs), carries a high level of risk and may result in losses exceeding your initial investment. These products are not suitable for all investors and should only be traded with funds you can afford to lose. You do not own or have any rights to the underlying assets of these derivatives (e.g., entitlement to dividends). Please ensure you fully understand the associated risks. Before trading, consider your level of experience, investment objectives, and seek independent financial advice if necessary. Refer to our legal documents and disclosures before making any trading decisions.

General Advice Warning:
The information provided on this website is general in nature and does not take into account your personal objectives, financial situation, or needs. Before acting on any advice, you should assess its appropriateness in light of your individual circumstances and consult our legal documentation.

Regional Restrictions:
The information and services on this website are not intended for residents of certain jurisdictions, including but not limited to the United States, Singapore, and any jurisdictions subject to international sanctions. For further information, please contact our customer support team.

Regulatory Information:

Ultima Markets is a trading name shared amongst multiple entities operating in various jurisdictions. These following entities are authorised to operate under the Ultima Markets brand and trademarks.

  • Ultima Markets UK Limited, reference number 470325, is authorised and regulated by the Financial Conduct Authority (FCA). Registered address: 1 Blossom Yard, Fourth Floor, London, E1 6RS, UNITED KINGDOM.

  • Ultima Markets Ltd is authorised and regulated by the Financial Services Commission (FSC) of Mauritius as a Full-Service Investment Dealer (excluding Underwriting), under licence number GB 23201593.

    Registered address: 2nd Floor, The Catalyst, 40 Silicon Avenue, Ebene Cybercity, 72201, Mauritius.

Ultima Markets Logo in Black Colour

Copyright © 2025 Ultima Markets Ltd. All rights reserved.

Hi, how can we help you?
打开 linee 的二维码